These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26855811)

  • 1. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.
    Soubières AA; Poullis A
    World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):41-50. PubMed ID: 26855811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.
    Soubières AA; Poullis A
    Inflamm Bowel Dis; 2016 Aug; 22(8):2016-22. PubMed ID: 27416044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory markers in ulcerative colitis: Current insights and future advances.
    Cioffi M; Rosa AD; Serao R; Picone I; Vietri MT
    World J Gastrointest Pathophysiol; 2015 Feb; 6(1):13-22. PubMed ID: 25685607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies.
    Longo S; Chieppa M; Cossa LG; Spinelli CC; Greco M; Maffia M; Giudetti AM
    Proteomes; 2020 Aug; 8(3):. PubMed ID: 32784952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin: Management in inflammatory bowel disease.
    Benítez JM; García-Sánchez V
    World J Gastrointest Pathophysiol; 2015 Nov; 6(4):203-9. PubMed ID: 26600978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.
    Ballard BR; M'Koma AE
    World J Gastrointest Endosc; 2015 Jun; 7(7):670-4. PubMed ID: 26140094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.
    Tontini GE; Vecchi M; Pastorelli L; Neurath MF; Neumann H
    World J Gastroenterol; 2015 Jan; 21(1):21-46. PubMed ID: 25574078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Miranda-García P; Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
    Yu YR; Rodriguez JR
    Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in inflammatory bowel disease: current practices and recent advances.
    Iskandar HN; Ciorba MA
    Transl Res; 2012 Apr; 159(4):313-25. PubMed ID: 22424434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin or Lactoferrin: Do They Help.
    Wright EK
    Dig Dis; 2016; 34(1-2):98-104. PubMed ID: 26982329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Biomarkers for Inflammatory Bowel Disease.
    Chen P; Zhou G; Lin J; Li L; Zeng Z; Chen M; Zhang S
    Front Med (Lausanne); 2020; 7():123. PubMed ID: 32391365
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.
    Barnes EL; Liew CC; Chao S; Burakoff R
    World J Gastrointest Endosc; 2015 Nov; 7(17):1233-7. PubMed ID: 26634038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.